Global / PharmaBoardroom's Top Patient Group Insights 2021
PharmaBoardroom has spoken to leaders from several important global patient advocacy organisations in 2021 who…
Top Stories
Download / InFocus Biotechs to Watch Switzerland 2021
Home to the pharmaceutical heavyweights, Novartis and Roche, elite contract manufacturers and a dizzying array of acclaimed research institutions and medical institutes, Switzerland has long stood proud as a true…
Japan / PMDA Chief Executive Yasuhiro Fujiwara on Regulatory Utilisation of RWD & RWE
Writing in the October edition of DIA’s Global Forum magazine, Chief Executive of Japan’s Pharmaceuticals and…
Saudi Arabia / Vision 2030 Healthcare Transformation Explained
Saudi Arabia’s ambitious Vision 2030 economic transformation plan aims at transitioning the Middle East’s…
Turkey / Boehringer Ingelheim Announces Contract Manufacturing Partnership with Abdi Ibrahim
Boehringer Ingelheim (BI), the largest private pharma company in the world, has become the latest Big Pharma player…
Brazil / Pfizer to Vaccinate Entire City; Biomm/CanSino Import Deal; Butantan’s Plans to Export Sinovac Vaccine
The latest news from Brazil, including Pfizer’s plans to vaccinate the entire Brazilian city of Toledo, what the…
Asia-Pacific / Cytiva's Francis Van Parys Talks Post-Pandemic Localisation, the APAC Talent Crunch, and Cell & Gene Opportunities
Francis Van Parys, vice president commercial Asia-Pacific at Cytiva, a global life sciences leader dedicated to…
Latest Reports
In Conversation
Lorna Warwick – CEO, Lymphoma Coalition
Lorna Warwick is CEO of the Lymphoma Coalition, a worldwide network of patient groups with a full or partial focus on providing support to patients with lymphoma. In this wide-ranging interview, Warwick highlights the progress made in lymphoma treatment in recent years and the work still to be done to better integrate authentic patient experiences and insights into the drug…
Gözde Güllüoğlu – General Manager Turkey…
After being present in the Turkish market for more than 28 years, MSD seems confident that it will be able…
Ahmed Aljedai – Assistant Deputy Minister of…
Prof. Ahmed Aljedai, assistant deputy minister of therapeutic affairs for support services at Saudi Arabia’s Ministry of Health (MoH) outlines…
Focus on USA
USA: Drug Innovations Are Delivering for Patients; We Need…
John M. O’Brien, recently appointed president and CEO of the US National Pharmaceutical Council, calls for innovation in benefit design reform to match the unparalleled speed and ingenuity with which…
Sanofi Genzyme EVP Bill Sibold Reflects on 30 Years of Rare…
Bill Sibold, Executive Vice President and Head of Sanofi Genzyme, highlights the achievements of the company’s Rare Humanitarian Program over the last 30 years, bringing treatments to patients in developing…
NORD’s Breakthrough Summit: Listening to the Rare Disease…
The National Organization for Rare Disorders (NORD) is set to host its annual Rare Diseases and Orphan Products Breakthrough Summit on October 18-19th. Ahead of the Summit, the Chair of…
Top 2021 Insights from Global Regulators
Over the past 12 months, PharmaBoardroom has spoken to the heads of several key regulatory bodies across the world. While the approval processes for COVID-19 vaccines have evidently been top…
Read more: USA >>
Focus on Turkey
Turkey: A Pharma Talent Hotbed
Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has compiled a strategic overview of Turkey’s pharma talent potential, including what local talent can offer…
Pharma Faces: Demet Russ, Janssen Turkey
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
10 Turkish Pharma Execs Talk Investment Strategies
In the world’s 18th largest market, recent pricing struggles have pushed some companies to revaluate their investment approach. Multinational organizations are complying with localization policies but are divided between having…
Boehringer Ingelheim Announces Contract Manufacturing…
Boehringer Ingelheim (BI), the largest private pharma company in the world, has become the latest Big Pharma player to commit to Turkish localization after announcing a contract manufacturing partnership with…
Read more: Turkey >>
Focus on Saudi Arabia
Lilly Signs Saudi MoU for Insulin Manufacturing
Saudi Arabia has one of the highest rates of diabetes in the world – over 17 percent of the population are diabetic – making the supply of insulin products a…
Saudi Arabia’s Vision 2030 Healthcare Transformation…
Saudi Arabia’s ambitious Vision 2030 economic transformation plan aims at transitioning the Middle East’s largest economy away from an over-reliance on fossil fuels and into a more diversified modern nation.…
Three Key Trends to Watch in Saudi Arabia’s Pharma…
Looking to diversify its economy while simultaneously improving its healthcare system, Saudi Arabia has been rolling out incentives for international companies to invest in local manufacturing. Here are three trends…
PharmaBoardroom’s Top 10 Most Read Interviews of 2021 (So…
PharmaBoardroom has spread its wings far and wide in 2021 (albeit digitally!), from well covered markets such as Singapore and Switzerland to new frontiers like Saudi Arabia. Our interviewees have…
Read more: Saudi Arabia >>
Focus on Europe
3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing between vaccination rates in developed and developing economies and…
Top 2021 Insights from Global Regulators
Over the past 12 months, PharmaBoardroom has spoken to the heads of several key regulatory bodies across the world. While the approval processes for COVID-19 vaccines have evidently been top…
Top 5 Pharma R&D Spenders in Europe
The Top Five countries in Europe ranked by amount spent on pharma R&D. While some of the continent’s largest and most developed nations are represented, other smaller countries are punching…
Top 5 Countries for Pharma Production in Europe
The Top Five countries in Europe for pharma production. All located in Western Europe, Switzerland punches well above its weight to take top spot. This data is taken from the 2021…
Read more: Europe >>
Focus on APAC
Decentralised Clinical Trials in APAC Here to Stay
Writing in the July issue of DIA’s Global Forum magazine Serene Ong and Gaurang Majmudar of clinical trial logistics specialists Marken outline why the shift to decentralised clinical trials brought…
5 Management Tips from APAC Life Science Leaders
The Asia-Pacific (APAC) region is home to around 1.44 billion people, over 60 percent of the world’s population, and a vast diversity of cultures, infrastructures, and economic development. Managing a…
Regulatory Cooperation & Joint Assessments in ASEAN
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia's National Pharmaceutical Regulatory Agency; Tharnkamol Chanprapaph of the Thai FDA; and Samvel Azatyan, Valerio Reggi, and…
APAC: Self-Medication in the Age of COVID: The…
Writing in the May edition of DIA’s Global Forum magazine, Toshiyoshi Tominaga of the Asia-Pacific Self-Medication Industry (APSMI) looks at the landscape for OTC medicines in the Asia-Pacific region today. Tominaga highlights…
Read more: APAC >>
Focus on Vaccines
3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing between vaccination rates in developed and developing economies and…
Brazil Vaccine News: Pfizer to Vaccinate Entire City;…
The latest news from Brazil, including Pfizer’s plans to vaccinate the entire Brazilian city of Toledo, what the US can learn from Brazil’s successful vaccine campaign, and a new deal…
Russia Pharma News: WHO Sputnik V Suspension; Vaccine…
The latest news from Russian healthcare and life sciences, including the WHO’s decision to suspend the approval process for the country’s Sputnik V COVID vaccine, hesitant uptake of Sputnik V…
India Pharma News: Piramal Demerges Pharma Business;…
The latest news from Indian pharm and healthcare, including Piramal Enterprises’ decision to demerge and list its pharma arm, the country’s 15 pharma billionaires, Danish CNS firm Lundbeck’s decision to…